Ad is loading...
AUPH
Price
$8.12
Change
-$0.21 (-2.52%)
Updated
Nov 15 closing price
107 days until earnings call
JSPR
Price
$20.43
Change
-$1.67 (-7.56%)
Updated
Nov 15 closing price
Ad is loading...

AUPH vs JSPR

Header iconAUPH vs JSPR Comparison
Open Charts AUPH vs JSPRBanner chart's image
Aurinia Pharmaceuticals
Price$8.12
Change-$0.21 (-2.52%)
Volume$1.44M
CapitalizationN/A
Jasper Therapeutics
Price$20.43
Change-$1.67 (-7.56%)
Volume$288.28K
CapitalizationN/A
AUPH vs JSPR Comparison Chart
Loading...
AUPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AUPH vs. JSPR commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUPH is a StrongSell and JSPR is a StrongSell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (AUPH: $8.12 vs. JSPR: $20.43)
Brand notoriety: AUPH and JSPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUPH: 126% vs. JSPR: 94%
Market capitalization -- AUPH: $1.16B vs. JSPR: $306.48M
AUPH [@Biotechnology] is valued at $1.16B. JSPR’s [@Biotechnology] market capitalization is $306.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUPH’s FA Score shows that 0 FA rating(s) are green whileJSPR’s FA Score has 1 green FA rating(s).

  • AUPH’s FA Score: 0 green, 5 red.
  • JSPR’s FA Score: 1 green, 4 red.
According to our system of comparison, JSPR is a better buy in the long-term than AUPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUPH’s TA Score shows that 4 TA indicator(s) are bullish while JSPR’s TA Score has 5 bullish TA indicator(s).

  • AUPH’s TA Score: 4 bullish, 4 bearish.
  • JSPR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AUPH is a better buy in the short-term than JSPR.

Price Growth

AUPH (@Biotechnology) experienced а -2.40% price change this week, while JSPR (@Biotechnology) price change was -16.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

AUPH is expected to report earnings on Mar 04, 2025.

JSPR is expected to report earnings on May 10, 2024.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUPH($1.16B) has a higher market cap than JSPR($306M). JSPR YTD gains are higher at: 158.935 vs. AUPH (-9.677). AUPH has higher annual earnings (EBITDA): -23.01M vs. JSPR (-67.01M). AUPH has more cash in the bank: 330M vs. JSPR (107M). JSPR has less debt than AUPH: JSPR (2.32M) vs AUPH (86M). AUPH has higher revenues than JSPR: AUPH (207M) vs JSPR (0).
AUPHJSPRAUPH / JSPR
Capitalization1.16B306M380%
EBITDA-23.01M-67.01M34%
Gain YTD-9.677158.935-6%
P/E RatioN/AN/A-
Revenue207M0-
Total Cash330M107M308%
Total Debt86M2.32M3,713%
FUNDAMENTALS RATINGS
AUPH: Fundamental Ratings
AUPH
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUPHJSPR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
58%
Momentum
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
60%
MACD
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
53%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 7 days ago
69%
Declines
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
68%
Aroon
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
63%
View a ticker or compare two or three
Ad is loading...
AUPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MRJSX10.94-0.01
-0.09%
Morgan Stanley Multi-Asset Real ReturnR6
PRGEX19.61-0.12
-0.61%
Pioneer Global Sustainable Equity R
SVFDX81.94-0.69
-0.84%
Smead Value R1
BOSOX20.00-0.26
-1.28%
Boston Trust Walden Small Cap
FIFQX22.88-0.36
-1.55%
Fidelity Advisor Founders C

AUPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUPH has been loosely correlated with JSPR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AUPH jumps, then JSPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUPH
1D Price
Change %
AUPH100%
-2.52%
JSPR - AUPH
44%
Loosely correlated
-7.56%
VCYT - AUPH
39%
Loosely correlated
-2.97%
LBPH - AUPH
37%
Loosely correlated
-0.08%
GOSS - AUPH
37%
Loosely correlated
-3.88%
BIOR - AUPH
34%
Loosely correlated
-10.92%
More

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
-7.56%
AUPH - JSPR
44%
Loosely correlated
-2.52%
OMGA - JSPR
43%
Loosely correlated
-17.98%
IMNM - JSPR
39%
Loosely correlated
-11.09%
ATNF - JSPR
38%
Loosely correlated
-6.72%
ATXI - JSPR
34%
Loosely correlated
+2.66%
More